Updated
Reviewed
Dec. 30, 2021
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Table 11. Antiretroviral Drug Use in Pregnant People with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy
Note: When using fixed-dose combination (FDC) tablets, refer to other sections in Appendix B and Table 11 in the Perinatal Guidelines for information about the dosing and safety of individual drug components of the FDC tablet during pregnancy.
| Table 11. Antiretroviral Drug Use in Pregnant People with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | |
|---|---|
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Table 11. Antiretroviral Drug Use in Pregnant People with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy
Note: When using fixed-dose combination (FDC) tablets, refer to other sections in Appendix B and Table 11 in the Perinatal Guidelines for information about the dosing and safety of individual drug components of the FDC tablet during pregnancy.
| Table 11. Antiretroviral Drug Use in Pregnant People with HIV: Pharmacokinetic and Toxicity Data in Human Pregnancy and Recommendations for Use in Pregnancy | |
|---|---|
Download Guidelines
- Section OnlyPDF (397.24 KB)
- Full GuidelinePDF (4.91 MB)
- Recommendations OnlyPDF (388.35 KB)
- Tables OnlyPDF (1.86 MB)